Ambroxol Hydrochloride Oral Solution

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

The main ingredient of this product is ambroxol hydrochloride.

It is suitable for treating thick sputum and difficulty in expectoration caused by acute and chronic respiratory diseases (such as acute and chronic bronchitis, bronchial asthma, bronchiectasis, tuberculosis, etc.).

Adults and children over 12 years old: Usually take 5 ml of solution orally 3 times a day for the first 2-3 days of treatment (equivalent to 90 mg of ambroxol hydrochloride per day). Then, take 5 ml of solution orally 2 times a day (equivalent to 60 mg of ambroxol hydrochloride per day). Take after meals. Note: The expectorant effect of this product can be increased with rehydration. Depending on the type of disease and its severity, your doctor will decide how long to take the medication. Do not take this product for more than 4-5 days without a doctor's supervision. If you forget to take 1 or less doses of this product, just follow the dosage instructions to take the next dose at the appropriate time.

There may be upper abdominal discomfort, poor appetite, diarrhea, and occasionally rash.

1. Patients who are allergic to the active ingredient of the oral solution: ambroxol hydrochloride or any other component are prohibited from taking this product. 2. Patients with the following conditions must use this product under specific conditions and special supervision. And consult a doctor. Even if the above measures have been taken before, they should continue to do so. Patients with renal insufficiency or severe liver disease should be particularly cautious when taking this product (such as extending the interval between two doses or taking a small dose). Patients with some rare bronchial diseases accompanied by excessive secretions (such as ciliary asthenia syndrome) should be careful when taking this product orally and must take it under the guidance of a physician because it may cause secretions to block the bronchus.

If used with antitussives (cough suppressants), there is a risk of blockage of secretions due to a weakened cough reflex, so the therapeutic range of the drug must be carefully considered before combined use. If used with antibiotics (amoxicillin, cefuroxime, erythromycin or doxycycline), the penetration of the antibiotic into the lung tissue may be increased.

Keep in a dark place and sealed (10-30℃).

100 ml: 0.3 g

China Resources Sanjiu (NanChang) Pharmaceutical Co., Ltd.

• Founded in:

  2000-10-20

• Address:

  No. 398 Dongsheng Avenue, Changdong Industrial Zone, Qingshan Lake District, Nanchang City, Jiangxi Province

• Tax NO.:

  913601007239228188

• Registered Funds:

  70.39 million yuan

• Website:

  Log in to view

• Email:

  Log in to view